Home › Sarcoma ng Malambot na Tisyu › Missouri › St. Louis
Pag-aaral pangklinika para sa Sarcoma ng Malambot na Tisyu sa St. Louis, MO
Isang pag-aaral para sa Sarcoma ng Malambot na Tisyu ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa St. Louis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
- Saint Louis University, St Louis
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Nagre-recruitPhase 1/2
- Washington University School of Medicine in St. Louis, St Louis
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Nagre-recruitPhase 1/2
- Washington University in St. Louis, St Louis
IDOV-Immune for Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Nagre-recruitPhase 1/2
- Washington University Medical Center, St Louis
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Nagre-recruitPhase 2
- Washington University in St. Louis, St Louis
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Nagre-recruitPhase 1
- Zai Lab Site 02005, St Louis
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Nagre-recruitPhase 1/2
- Washington University Infusion Center Pharmacy, St Louis
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Nagre-recruitPhase 2
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Washington University School of Medicine, St Louis
Pag-aaral para sa Sarcoma ng Malambot na Tisyu sa ibang lungsod
- Houston, TX32 pag-aaral
- New York City, NY20 pag-aaral
- Boston, MA17 pag-aaral
- Los Angeles, CA13 pag-aaral
- Columbus, OH12 pag-aaral
- Washington, DC11 pag-aaral
- Memphis, TN10 pag-aaral
- Philadelphia, PA9 pag-aaral
- Aurora, CO8 pag-aaral
- Nashville, TN8 pag-aaral
- Durham, NC8 pag-aaral
- Queens, NY8 pag-aaral
Iba pang pag-aaral sa St. Louis
- Non-Small Cell Lung Cancer68 pag-aaral
- Kanser sa Suso63 pag-aaral
- Metastatic Cancer52 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Colorectal Cancer51 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Ovary37 pag-aaral
- Kanser sa Baga37 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg32 pag-aaral
- Kanser ng Endometrium29 pag-aaral
- Multiple Myeloma26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.